(ABCL) - Analyst Ratings

(ABCL) – Analyst Ratings

Feb 22, 2024 09:40 AM Benchmark Upgrades AbCellera Biologics (ABCL) to Buy, 'R&D Progress Highlights 4Q23'
Dec 5, 2023 02:27 AM KeyBanc Starts AbCellera Biologics (ABCL) at Overweight
Nov 6, 2023 09:33 AM
Oct 13, 2023 04:02 AM
Feb 28, 2023 05:44 AM
Dec 15, 2022 03:59 AM
Nov 16, 2022 05:35 PM
Nov 16, 2022 06:17 AM
Sep 28, 2022 12:16 PM
Dec 21, 2021 06:06 AM
Nov 18, 2021 04:16 PM
Sep 20, 2021 07:10 AM
Jan 25, 2021 07:25 AM
Jan 5, 2021 06:45 AM
Jan 5, 2021 06:29 AM
Jan 5, 2021 06:28 AM
Jan 5, 2021 05:41 AM
Jan 5, 2021 05:37 AM